The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 23, 2019

Filed:

Mar. 11, 2016
Applicants:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Dong-ming Shen, Edison, NJ (US);

Christopher J. Sinz, Middletown, NJ (US);

Alejandro Crespo, Westfield, NJ (US);

Johnathan E. Wilson, South Orange, NJ (US);

Troy Mccracken, Berkeley Heights, NJ (US);

Shimin Xu, Beijing, CN;

Haitang LI, Beijing, CN;

Inventors:

Dong-Ming Shen, Edison, NJ (US);

Christopher J. Sinz, Middletown, NJ (US);

Alejandro Crespo, Westfield, NJ (US);

Johnathan E. Wilson, South Orange, NJ (US);

Troy McCracken, Berkeley Heights, NJ (US);

Shimin Xu, Beijing, CN;

Haitang Li, Beijing, CN;

Assignee:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); C07D 403/04 (2006.01); C07D 487/04 (2006.01); A61K 31/4192 (2006.01); A61K 31/4196 (2006.01); A61K 31/506 (2006.01); C07D 498/04 (2006.01); A61P 25/00 (2006.01);
U.S. Cl.
CPC ...
C07D 403/04 (2013.01); A61K 31/4192 (2013.01); A61K 31/4196 (2013.01); A61K 31/506 (2013.01); A61P 25/00 (2018.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 498/04 (2013.01);
Abstract

The present invention is directed to pyrimidine carboxamide compounds of formula I which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis, Parkinson's disease, Parkinson's disease dementia (PDD), or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.


Find Patent Forward Citations

Loading…